Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Forensic Toxicology
Erschienen in: Forensic Toxicology 2/2017

25.01.2017 | Review Article

α-Pyrrolidinophenones: a new wave of designer cathinones

verfasst von: Jolanta B. Zawilska, Jakub Wojcieszak

Erschienen in: Forensic Toxicology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Recent years have witnessed a rapid increase in the number and prevalence of novel psychoactive substances (NPSs). Among them, pyrovalerone derivatives, including 3,4-methylenedioxypyrovalerone (3,4-MDPV), α-pyrrolidinopentiophenone (α-PVP), α-pyrrolidinobutiophenone (α-PBP), α-pyrrolidinopropiophenone (α-PPP), α-pyrrolidinohexanophenone (α-PHP), α-pyrrolidinoheptanophenone (α-PHPP), α-pyrrolidinooctanophenone (α-POP) and their substituted analogs, form a subgroup of designer cathinones endowed with highly pronounced psychostimulant effects, and these deserve special attention by healthcare specialists. This review focuses on recent members of this group, their in vitro and in vivo mechanisms of action and pharmacological activities, and their main metabolic pathways. The toxic properties of pyrovalerone derivatives are summarized, along with numerous case reports of fatal and non-fatal intoxications. Pyrovalerone derivatives are also associated with a growing number of reports of DUID (driving under the influence of drugs) and multidrug abuse, suggesting that they should be considered as posing a serious threat to public health.
Literatur
1.
2.
3.
4.
5.
Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clin Toxicol 49:499–505. doi:10.​3109/​15563650.​2011.​590812 CrossRef
6.
7.
Giese C, Igoe D, Gibbons Z, Hurley C, Stokes S, McNamara S, Ennis O, O’Donnell K, Keenan E, De Gascun C, Lyons F, Ward M, Danis K, Glynn R, Waters A, Fitzgerald M, on behalf of the outbreak control team (2015) Injection of new psychoactive substance snow blow associated with recently acquired HIV infections among homeless people who inject drugs in Dublin, Ireland, 2015. Euro Surveill 20:1–6. doi:10.​2807/​1560-7917.​ES.​2015.​20.​40.​30036
8.
Adamowicz P, Gieroń J, Gil D, Lechowicz W, Skulska A, Tokarczyk B, Zuba D (2016) Blood concentrations of α-pyrrolidinovalerophenone (α-PVP) determined in 66 forensic samples. Forensic Toxicol 34:227–234. doi:10.​1007/​s11419-016-0306-0 CrossRef
9.
Byrska B, Zuba D, Stanaszek R (2016) Changes on the novel psychoactive substances (NPS) market in 2015 in response to the amendment to the Act on Counteracting Drug Addiction (Polish). XXXIII Conference of Forensic Toxicologists, Poznań, Poland, 11–13 May 2016, Abstract Book, pp 33–34
10.
11.
Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (2013) Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicol 31:223–240. doi:10.​1007/​s11419-015-0268-7 CrossRef
12.
Uchiyama N, Matsuda S, Kawamura M, Shimokawa Y, Kikura-Hanajiri R, Aritake K, Urade Y, Goda Y (2014) Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products. Forensic Sci Int 243:1–13. doi:10.​1016/​j.​forsciint.​2014.​03.​013 CrossRefPubMed
13.
Uchiyama N, Shimokawa Y, Kikura-Hanajiri R, Demizu Y, Goda Y, Hakamatsuka T (2015) A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI-indazole analog (MN-18), a phenethylamine derivative N-OH-EDMA and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products. Forensic Toxicol 33:244–259. doi:10.​1007/​s11419-015-0268-7 CrossRefPubMedPubMedCentral
14.
Majchrzak M, Rojkiewicz M, Celiński M, Kuś P, Sajewicz M (2016) Identification and characterization of new designer drug 4-fluoro-PV9 and α-PHP in the seized materials. Forensic Toxicol 34:115–124. doi:10.​1007/​s11419-015-0295-4 CrossRefPubMed
15.
16.
17.
18.
Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products. Neuropsychopharmacology 38:552–562. doi:10.​1038/​npp.​2012.​204 CrossRefPubMed
19.
Eshleman AJ, Wolfrum KM, Reed JF, Kim SO, Swanson T, Johnson RA, Janowsky A (2017) Structure-activity relationships of substituted cathinones, with transporter binding, uptake and release. J Pharmacol Exp Ther 360:33–47. doi:10.​1124/​jpet.​116.​236349 CrossRefPubMed
20.
21.
22.
23.
24.
Aarde SM, Creehan KM, Vandewater SA, Dickerson TJ, Taffe MA (2015) In vivo potency and efficacy of the novel cathinone α-pyrrrolidinopenthiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats. Psychopharmacology 232:3045–3055. doi:10.​1007/​s00213-015-3944-8 CrossRefPubMedPubMedCentral
25.
Smith DA, Negus SS, Poklis JL, Blough BE, Banks ML (2016) Cocaine-like discriminative stimulus effects of alpha-pyrrolidinovalerophenone, methcathinone and their 3,4-methylenedioxy or 4-methyl analogs in rhesus monkey. Addict Biol. doi:10.​1111/​adb.​12399
26.
27.
28.
29.
Watterson LR, Burrows BT, Hernandez RD, Moore KN, Grabenauer M, Marusich JA, Olive MF (2015) Effects of α-pyrrolidinopentiophenone and 4-methyl-N-ethylcathinone, two synthetic cathinones commonly found in second-generation “bath salts”, on intracranial self-stimulation thresholds in rats. Int J Neuropsychopharmacol 18(1):pyu014. doi:10.​1093/​ijnp/​pyu014
30.
Gregg RA, Hicks C, Nayak SU, Tallarida CS, Nucero P, Smith GR, Reitz AB, Rawls SM (2016) Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator. Neuropharmacology 108:111–119. doi:10.​1016/​j.​neuropharm.​2016.​04.​014 CrossRefPubMed
31.
McFarland K, Lapish CC, Kalivas PW (2003) Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23:3531–3537PubMed
32.
33.
Ellefsen KN, Wolhfarth A, Swortwood MJ, Diao X, Concheiro M, Huestis MA (2016) 4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry. Forensic Toxicol 34:61–75. doi:10.​0007/​s11419-015-0287-4 CrossRefPubMed
34.
35.
Matsuta S, Shima N, Kamata H, Kakehashi H, Nakano S, Sasaki K, Kamata T, Nishioka H, Miki A, Katagi M, Zaitsu K, Sato T, Tsuchihashi H, Suzuki K (2015) Metabolism of the designer drug α-pyrrolidinobutiophenone (α-PBP) in humans: identification and quantification of the phase I metabolites in urine. Forensic Sci Int 249:181–188. doi:10.​1016/​j.​forsciint.​2015.​02.​004 CrossRefPubMed
36.
Negreira N, Erratico C, Kosjek T, van Nuijs ALN, Heath E, Neels H, Covaci A (2015) In vitro phase I and phase II metabolism of α-pyrrolidinovalerophenone (α-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol. Anal Bioanal Chem 407:5803–5816. doi:10.​1007/​s00216-015-8763-6 CrossRefPubMed
37.
Peters FT, Meyer MR, Fritschi G, Maurer HH (2005) Studies on the metabolism and toxicological detection of the new designer drug 4′-methyl-α-pyrrolidinobutyrophenone (MPBP) in rat urine using gas chromatography-mass spectrometry. J Chromatogr B 824:81–91. doi:10.​1016/​j.​jchromb.​2005.​07.​003 CrossRef
38.
Shima N, Katagi M, Kamata H, Matsuta S, Sasaki K, Kamata T, Nishioka H, Miki A, Tatsuno M, Zaitsu K, Ishii K, Sato T, Tsuchihashi H, Suzuki K (2014) Metabolism of the newly encountered designer drug α-pyrrolidinovalerophenone in humans: identifications and quantitation of urinary metabolites. Forensic Toxicol 32:59–67. doi:10.​1007/​s11419-013-0202-9 CrossRef
39.
Springer D, Peters FT, Fritschi G, Maurer HH (2002) Metabolism and toxicological detection of the new designer drug 4′-methyl-α-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry. J Chromatogr B 773:25–33. doi:10.​1016/​S1570-0232(01)00578-5 CrossRef
40.
Springer D, Fritschi G, Maurer HH (2003) Metabolism and toxicological detection of the new designer drug 4′-methoxy-α-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry. J Chromatogr B 793:331–342. doi:10.​1016/​S1570-0232(03)00334-9 CrossRef
41.
Springer D, Peters FT, Fritschi G, Maurer HH (2003) New designer drug 4′-methyl-α-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. J Chromatogr B 789:79–91. doi:10.​1016/​S1570-0232(03)00043-6 CrossRef
42.
Swortwood MJ, Ellefsen KN, Wohlfarth A, Diao X, Concheiro-Guisan M, Kronstrand R, Huestis MA (2016) First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry. Anal Bioanal Chem 408:4845–4856. doi:10.​1007/​s00216-016-9599-4 CrossRefPubMed
43.
Meyer MR, Du P, Schuster F, Maurer HH (2010) Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS. J Mass Spectrom 45:1426–1442. doi:10.​1002/​jms.​1859 CrossRefPubMed
44.
Strano-Rossi S, Cadwallader AB, de la Torre X, Botrè F (2010) Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 24:2706–2714. doi:10.​1002/​rcm.​4692 CrossRefPubMed
45.
Ibáñez M, Pozo ÓJ, Sancho JV, Orengo T, Haro G, Hernández F (2016) Analytical strategy to investigate 3,4-methylenedioxypyrovalerone (MDPV) metabolites in consumers’ urine by high-resolution mass spectrometry. Anal Bioanal Chem 408:151–164. doi:10.​1007/​s00216-015-9088-1 CrossRefPubMed
46.
Uralets V, Rana S, Morgan S, Ross W (2014) Testing for designer stimulants: metabolic profiles of 16 synthetic cathinones excreted free in human urine. J Anal Toxicol 38:233–241. doi:10.​1093/​jat/​bku021 CrossRefPubMed
47.
Tyrkkö E, Pelander A, Ketola RA, Ojanperä I (2013) In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry. Anal Bioanal Chem 405:6697–6709. doi:10.​1007/​s00216-013-7137-1 CrossRefPubMed
48.
Paul M, Bleicher S, Guber S, Ippisch J, Polettini A, Schultis W (2015) Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-fight mass spectrometry. J Mass Spectrom 50:1305–1317. doi:10.​1002/​jms.​3642 CrossRefPubMed
49.
Shima N, Kakehashi H, Matsuta S, Kamata H, Nakano S, Sasaki K, Kamata T, Nishioka H, Zaitsu K, Sato T, Miki A, Katagi M, Tsuchihashi H (2015) Urinary excretion and metabolism of the α-pyrrolidinophenone designer drug 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one (PV9) in humans. Forensic Toxicol 33:279–294. doi:10.​1007/​s11419-015-0274-9 CrossRef
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
Beck O, Franzén L, Bäckberg M, Signell P, Helander A (2016) Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project. Clin Toxicol 54:568–575. doi:10.​1080/​15563650.​2016.​1190979 CrossRef
64.
65.
66.
67.
68.
69.
70.
Fujita Y, Koeda A, Fujino Y, Onodera M, Kikuchi S, Niitsu H, Iwasaki Y, Usuo K, Inoue Y (2016) Clinical and toxicological findings of acute intoxication with synthetic cannabinoids and cathinones. Acute Med Surg 3:230–236. doi:10.​1002/​ams2.​182 CrossRef
71.
Klavž J, Gorenjak M, Marinšek M (2016) Suicide attempt with a mix of synthetic cannabinoids and synthetic cathinones: case report of non-fatal intoxication with AB-CHMINACA, AB-FUBINACA, alpha-PHP, alpha-PVP and 4-CMC. Forensic Sci Int 265:121–124. doi:10.​1016/​j.​forsciint.​2016.​01.​018 CrossRefPubMed
72.
73.
74.
Namera A, Urabe S, Saito T, Torikoshi-Hatano A, Shiraishi H, Arima Y, Nagao M (2013) A fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of α-pyrrolidinobutiophenone and α-pyrrolidinovalerophenone in blood and/or hair. Forensic Toxicol 31:338–343. doi:10.​1007/​s11419-013-0192-7 CrossRef
75.
76.
Sellors K, Jones A, Chan B (2014) Death due to intravenous use of α-pyrrolidinopentiophenone. Med J Aust 201:601–603CrossRefPubMed
77.
Nagai H, Saka K, Nakajima M, Maeda H, Kuroda R, Igarashi A, Tsujimura-Ito T, Nara A, Komori M, Yoshida K (2014) Sudden death after sustained restraint following self-administration of the designer drug α-pyrrolidinovalerophenone. Int J Cardiol 172:263–265. doi:10.​1016/​j.​ijcard.​2013.​12.​262 CrossRefPubMed
78.
Minakata K, Yamagishi I, Nozawa H, Hasegawa K, Wurita A, Gonmori K, Suzuki M, Watanabe K, Suzuki O (2014) MALDI-TOF mass spectrometric determination of four pyrrolidino cathinones in human blood. Forensic Toxicol 32:169–175. doi:10.​1007/​s11419-013-0212-7 CrossRef
79.
Hasegawa K, Suzuki O, Wurita A, Minakata K, Yamagishi I, Nozawa H, Gonmori K, Watanabe K (2014) Postmortem distribution of α-pyrrolidinovalerophenone and its metabolite in body fluid and solid tissues in a fatal poisoning case measured by LC-MS-MS with the standard addition method. Forensic Toxicol 32:225–234. doi:10.​1007/​s11419-014-0227-8 CrossRef
80.
Adamowicz P, Gieroń J, Gil D, Lechowicz W, Skulska A, Tokarczyk B (2015) The prevalence of new psychoactive substances in biological material—a three-year review of casework in Poland. Drug Test Anal 8:63–70. doi:10.​1002/​dta.​1924 CrossRefPubMed
81.
82.
83.
Kula K, Rojek S, Maciów-Głąb M, Kłys M (2016) α-PVP in fatal cases (Polish). XXXIII Conference of Forensic Toxicologists, Poznań, Poland, 11–13 May 2016, Abstract Book, pp 49–50
84.
Wurita A, Hasegawa K, Minakata K, Gonmori K, Nozawa H, Yamagishi I, Suzuki O, Watanabe K (2014) Postmortem distribution of α-pyrrolidinobutiophenone in body fluids and solid tissues of a human cadaver. Leg Med 16:241–246. doi:10.​1016/​j.​legalmed.​2014.​05.​001 CrossRef
85.
Shintani-Ishida K, Nakamura M, Tojo M, Idota N, Ikegaya H (2015) Identification and quantification of 4′-methoxy-α-pyrrolidinobutiophenone (4-MeOPBP) in human plasma and urine using LC-TOF-MS in an autopsy case. Forensic Toxicol 33:348–354. doi:10.​1007/​s11419-015-0281-x CrossRef
86.
87.
Hasegawa K, Wurita A, Minakata K, Gonmori K, Nozawa H, Yamagishi I, Watanabe K, Suzuki O (2015) Postmortem distribution of PV9, a new cathinone derivative, in human solid tissues in a fatal poisoning case. Forensic Toxicol 33:141–147. doi:10.​1007/​s11419-014-0262-5 CrossRef
88.
89.
Kudo K, Usumoto Y, Kikura-Hanajiri R, Sameshima N, Tsuji A, Ikeda N (2015) A fatal case of poisoning related to new cathinone designer drugs, 4-methoxy PV8, PV9, and 4-methoxy PV9, and a dissociative agent, diphenidine. Leg Med 17:421–426. doi:10.​1016/​j.​legalmed.​2015.​06.​005 CrossRef
90.
Kriikku P, Rintatalo J, Pihlainen K, Hurme J, Ojanperä I (2015) The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland. Int J Legal Med 129:741–749. doi:10.​1007/​s00414-015-1184-4 CrossRefPubMed
91.
92.
93.
Metadaten
Titel
α-Pyrrolidinophenones: a new wave of designer cathinones
verfasst von
Jolanta B. Zawilska
Jakub Wojcieszak
Publikationsdatum
25.01.2017
Verlag
Springer Japan
Erschienen in
Forensic Toxicology / Ausgabe 2/2017
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-016-0353-6

Weitere Artikel der Ausgabe 2/2017

Forensic Toxicology 2/2017 Zur Ausgabe

Original Article

Sensitive identification and quantitation of parent forms of six synthetic cannabinoids in urine samples of human cadavers by liquid chromatography–tandem mass spectrometry

Review Article

Acryloylfentanyl, a recently emerged new psychoactive substance: a comprehensive review

Original Article

In vitro metabolism of new synthetic cannabinoid SDB-006 in human hepatocytes by high-resolution mass spectrometry

Original Article

In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA

Original Article

Identification and structural characterization of four novel synthetic cathinones: α-methylaminohexanophenone (hexedrone, HEX), 4-bromoethcathinone (4-BEC), 4-chloro-α-pyrrolidinopropiophenone (4-Cl-PPP), and 4-bromo-α-pyrrolidinopentiophenone (4-Br-PVP) after their seizures

Short Communication

25I-NBOH: a new potent serotonin 5-HT2A receptor agonist identified in blotter paper seizures in Brazil

Neu im Fachgebiet Rechtsmedizin

01.04.2024 | Forensische Traumatologie | CME

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Open Access 22.02.2024 | Pathologie | Originalien

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

21.02.2024 | Thrombozytopenie | CME

Knochenmarkhistologie bei Zytopenien
Beitrag zur hämatologischen Differenzialdiagnostik

Open Access 21.02.2024 | Fettleber | Originalien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien
Automatische Quantifizierung von Leberverfettung